» Articles » PMID: 36358855

Autotaxin in Breast Cancer: Role, Epigenetic Regulation and Clinical Implications

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2022 Nov 11
PMID 36358855
Authors
Affiliations
Soon will be listed here.
Abstract

Autotaxin (ATX), the protein product of Ectonucleotide Pyrophosphatase Phosphodiesterase 2 (), is a secreted lysophospholipase D (lysoPLD) responsible for the extracellular production of lysophosphatidic acid (LPA). ATX-LPA pathway signaling participates in several normal biological functions, but it has also been connected to cancer progression, metastasis and inflammatory processes. Significant research has established a role in breast cancer and it has been suggested as a therapeutic target and/or a clinically relevant biomarker. Recently, methylation was described, revealing a potential for clinical exploitation in liquid biopsy. The current review aims to gather the latest findings about aberrant signaling through ATX-LPA in breast cancer and discusses the role of expression and epigenetic modification, giving insights with translational value.

Citing Articles

Structure-Based Discovery of MolPort-137: A Novel Autotaxin Inhibitor That Improves Paclitaxel Efficacy.

Rai P, Clark C, Kardam V, Womack C, Thammathong J, Norman D Int J Mol Sci. 2025; 26(2).

PMID: 39859312 PMC: 11765394. DOI: 10.3390/ijms26020597.


ENPP2 promotes progression and lipid accumulation via AMPK/SREBP1/FAS pathway in chronic lymphocytic leukemia.

Lu L, Hu X, Han Y, Wang H, Tian Z, Zhang Y Cell Mol Biol Lett. 2024; 29(1):159.

PMID: 39731014 PMC: 11681649. DOI: 10.1186/s11658-024-00675-6.


Autotaxin Expression in the Uterus of Cycling Rats.

Kim H, Lee S Dev Reprod. 2024; 28(3):67-74.

PMID: 39444640 PMC: 11495881. DOI: 10.12717/DR.2024.28.3.67.


The Effect of Ionizing Irradiation on the Autotaxin-Lysophasphatidic Acid Axis and Interleukin-6/8 Secretion in Different Breast Cancer Cell Lines.

Promny T, Scherrer I, Kadam S, Schmid R, Jost T, Distel L J Pers Med. 2024; 14(9).

PMID: 39338222 PMC: 11433306. DOI: 10.3390/jpm14090968.


Biomarkers Identification in the Microenvironment of Oral Squamous Cell Carcinoma: A Systematic Review of Proteomic Studies.

Pomella S, Melaiu O, Cifaldi L, Bei R, Gargari M, Campanella V Int J Mol Sci. 2024; 25(16).

PMID: 39201614 PMC: 11354375. DOI: 10.3390/ijms25168929.


References
1.
Benesch M, Zhao Y, Curtis J, McMullen T, Brindley D . Regulation of autotaxin expression and secretion by lysophosphatidate and sphingosine 1-phosphate. J Lipid Res. 2015; 56(6):1134-44. PMC: 4442871. DOI: 10.1194/jlr.M057661. View

2.
Jansen S, Stefan C, Creemers J, Waelkens E, Van Eynde A, Stalmans W . Proteolytic maturation and activation of autotaxin (NPP2), a secreted metastasis-enhancing lysophospholipase D. J Cell Sci. 2005; 118(Pt 14):3081-9. DOI: 10.1242/jcs.02438. View

3.
Knowlden S, Georas S . The autotaxin-LPA axis emerges as a novel regulator of lymphocyte homing and inflammation. J Immunol. 2014; 192(3):851-7. PMC: 3905607. DOI: 10.4049/jimmunol.1302831. View

4.
Nouh M, Wu X, Okazoe H, Tsunemori H, Haba R, Abou-Zeid A . Expression of autotaxin and acylglycerol kinase in prostate cancer: association with cancer development and progression. Cancer Sci. 2009; 100(9):1631-8. PMC: 11158477. DOI: 10.1111/j.1349-7006.2009.01234.x. View

5.
Frisca F, Sabbadini R, Goldshmit Y, Pebay A . Biological effects of lysophosphatidic acid in the nervous system. Int Rev Cell Mol Biol. 2012; 296:273-322. DOI: 10.1016/B978-0-12-394307-1.00005-9. View